Finally, when exploring differences in metabolic and renal variables across stages of NAFLD, patients in the higher stages of the disease showed higher levels of hepatic iron load and fasting insulin, and higher scores of HOMA-IR, as compared to patients in stage 1. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.